Online citations, reference lists, and bibliographies.
← Back to Search

Synthesis And Characterisation Of Magnetic Nanoparticles In Medicine

A. Majid, W. Ahmed, Yogita Patil-Sen, Tapas Sen
Published 2018 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
The idea of using magnetic nanomaterials in biomedical applications has been studied since last decades. Magnetic nanomaterials have been found as a promising candidate in biological applications. This chapter presented the diverse approach to engineer the nanoparticles for targeted applications. Superparamagnetic iron oxide nanoparticle (SPION) cores of 10–25 nm were synthesised using co-precipitation method iron (II) and iron (III) salts in alkaline medium. The superparamagnetic behaviour is an ideal solid support for the hyperthermia ablation and magnetic field-triggered stimuli for drug release. These cores were further coated with mesoporous silica rendering them versatile materials, which can enhance the stability, drug-loading capacity and its release in controllable manner. Moreover, their promising applications as magnetic field-triggered hyperthermia ablation and magnetic field-triggered controlled-release drug delivery combining both thermos-chemotherapy system.
This paper references
10.3109/02656739709023559
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
A. Jordan (1997)
10.1016/J.JMMM.2004.06.032
Synthesis, characterisation and application of silica-magnetite nanocomposites
I. Bruce (2004)
10.1016/J.MATLET.2016.05.048
A novel method for preparation of bare and poly(vinylpyrrolidone) coated superparamagnetic iron oxide nanoparticles for biomedical applications
Isa Karimzadeh (2016)
10.1016/J.JMMM.2009.05.020
Studies of magnetite nanoparticles synthesized by thermal decomposition of iron (III) acetylacetonate in tri(ethylene glycol)
D. Maity (2009)
10.2307/3578256
Critical steps for induction of chromosomal aberrations in CHO cells heated in S phase.
R. Wong (1993)
10.4236/WJNSE.2012.23020
Modified Scherrer Equation to Estimate More Accurately Nano-Crystallite Size Using XRD
A. Monshi (2012)
10.1117/12.2084285
Utility and translatability of mathematical modeling, cell culture and small and large animal models in magnetic nanoparticle hyperthermia cancer treatment research
P. Hoopes (2015)
10.1039/c2nr33417h
A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
N. Knežević (2013)
10.1088/0022-3727/46/10/105003
Surface functionalized LSMO nanoparticles with improved colloidal stability for hyperthermia applications
N. Thorat (2013)
10.3390/nano4020331
Synthesis Characterization and Photocatalytic Studies of Cobalt Ferrite-Silica-Titania Nanocomposites
D. Greene (2014)
10.1080/02656730802104757
Clinical applications of magnetic nanoparticles for hyperthermia
B. Thiesen (2008)
10.1016/S0304-8853(03)00426-8
Size dependence of specific power absorption of Fe3O4 particles in AC magnetic field
M. Ma (2004)
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
P. Vaupel (1989)
10.1016/j.colsurfb.2014.07.019
Enhanced specific absorption rate in silanol functionalized Fe3O4 core-shell nanoparticles: study of Fe leaching in Fe3O4 and hyperthermia in L929 and HeLa cells.
J. Majeed (2014)
10.2174/1389200217666160607232540
Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
M. Shevtsov (2016)
10.1007/978-0-387-85600-1_20
APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE
C. Bárcena (2003)
10.1039/C2RA20199B
Simple one-pot fabrication of ultra-stable core-shell superparamagnetic nanoparticles for potential application in drug delivery
Tapas Sen (2012)
10.1016/J.COLSURFA.2008.06.024
Synthesis of Fe3O4/APTES/PEG diacid functionalized magnetic nanoparticles for MR imaging
B. Feng (2008)
10.1002/BEM.2250130710
Magnetite in human tissues: a mechanism for the biological effects of weak ELF magnetic fields.
J. Kirschvink (1992)
10.1016/S0360-3016(97)00731-1
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
P. Sneed (1998)
10.1002/9783527631544
Nanoparticles : from theory to application
Geunther Schmid (2010)
10.1097/00000658-195710000-00007
Selective Inductive Heating of Lymph Nodes
R. Gilchrist (1957)
10.1063/1.4821020
Fe-based nanoparticles as tunable magnetic particle hyperthermia agents
K. Simeonidis (2013)
10.1039/C1JM10092K
Induction heating studies of Fe3O4 magnetic nanoparticles capped with oleic acid and polyethylene glycol for hyperthermia
Runa Ghosh (2011)
10.1088/2053-1591/1/2/026107
Realization of highest specific absorption rate near superparamagnetic limit of CoFe2O4 colloids for magnetic hyperthermia applications
M. K. Surendra (2014)
10.1021/JA061393Q
Mesoporous silica-magnetite nanocomposite: fabrication and applications in magnetic bioseparations.
Tapas Sen (2006)
10.1016/J.JMMM.2006.11.179
Magnetite ferrofluid with high specific absorption rate for application in hyperthermia
Li-ying Zhang (2007)
10.1039/c5nr02718g
Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.
Christopher A Quinto (2015)
10.1103/PHYSREV.130.1677
Thermal Fluctuations of a Single-Domain Particle
J. W. F. Brown (1963)
Metabolic aspects of the role of hyperthermia im mammalian cell inactivation and their possible relevance to cancer treatment.
G. Hahn (1974)
10.1016/J.JMMM.2009.09.050
Enhancing remote controlled heating characteristics in hydrophilic magnetite nanoparticles via facile co-precipitation
Reynolds A. Frimpong (2010)
10.1016/J.MICROMESO.2008.07.028
Mesoporous silica-coated superparamagnetic magnetite functionalized with CuO and its application as a desulfurizer
Lingling Qu (2009)
10.1039/c3cs60058k
Magnetic responsive polymer composite materials.
Julie Thévenot (2013)
10.1016/J.JSSC.2011.12.011
Synthesis of high intrinsic loss power aqueous ferrofluids of iron oxide nanoparticles by citric acid-assisted hydrothermal-reduction route
B. Behdadfar (2012)
10.1136/bmj.4.5946.679
Clinical Effects of Whole-body Hyperthermia in Advanced Malignancy
R. T. Pettigrew (1974)
10.1016/J.JALLCOM.2016.05.246
Fabrication and size dependent magnetic studies of Ni x Mn 1−x Fe 2 O 4 (x = 0.2) cubic nanoplates
K. Maaz (2016)
10.1039/c4nr03482a
Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.
Aziliz Hervault (2014)
10.1378/chest.07-2190
Therapeutic hypothermia: past, present, and future.
J. Varon (2008)
10.1016/J.JMMM.2017.02.015
A method for increasing the homogeneity of the temperature distribution during magnetic fluid hyperthermia with a Fe-Cr-Nb-B alloy in the presence of blood vessels
Yun-dong Tang (2017)
10.2307/3578175
Hyperthermia induces apoptosis in thymocytes.
K. Sellins (1991)
10.1080/09553000010024687
Hyperthermic radiosensitization: mode of action and clinical relevance
H. Kampinga (2001)
10.1038/srep05020
Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings
Usawadee Sakulkhu (2014)
10.1155/2014/705068
Characterization of Modified Magnetite Nanoparticles for Albumin Immobilization
A. Bordbar (2014)
10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#
Selective heat sensitivity of cancer cells. Biochemical and clinical studies
R. Cavaliere (1967)
10.1016/J.JMMM.2004.11.005
Preparation of magnetic nanoparticles with large specific loss power for heating applications
R. Muller (2005)
10.1016/J.MICROMESO.2008.11.012
Mesoporous silica–magnetite nanocomposites: Fabrication, characterisation and applications in biosciences
Tapas Sen (2009)
10.1016/S0304-8853(99)00088-8
Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles
A. Jordan (1999)
10.1039/C6RA18567C
Facile synthesis of novel hydrophilic and carboxyl-amine functionalized superparamagnetic iron oxide nanoparticles for biomedical applications
G. Kandasamy (2016)
10.1039/B402025A
Magnetic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
10.1039/C5RA11765H
Synthesis and characterization of new modified silica coated magnetite nanoparticles with bisaldehyde as selective adsorbents of Ag(I) from aqueous samples
A. Banaei (2015)
10.1201/b18948
Introduction to Magnetism and Magnetic Materials
D. Jiles (2015)
10.3109/02656736.2015.1005178
Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer
Anilchandra Attaluri (2015)
10.1021/nn2048137
Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment.
P. Guardia (2012)
10.1006/EXCR.1998.4203
Nuclear translocation and increased expression of Bax and disturbance in cell cycle progression without prominent apoptosis induced by hyperthermia.
M. Nishita (1998)
10.1007/s11060-010-0389-0
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
K. Maier-Hauff (2010)
10.1016/J.MSEC.2006.05.027
Magnetic PNIPA hydrogels for hyperthermia applications in cancer therapy
K.L. Ang (2007)
Polymer Stabilized Magnetite Nanoparticles and Poly(propylene oxide) Modified Styrene-Dimethacrylate Networks
L. Harris (2002)
10.1016/S0360-3016(96)00363-X
A phase I and II clinical trial of a newly developed ultrasound hyperthermia system with an improved planar transducer.
M. Mitsumori (1996)
10.1016/j.canlet.2013.04.032
Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
P. Santhosh (2013)
10.1007/978-3-642-81080-0
Selective Heat Sensitivity of Cancer Cells
A. Rossi-Fanelli (1977)
10.1016/J.JMMM.2014.10.109
Magnetic hyperthermia with hard-magnetic nanoparticles
B. E. Kashevsky (2015)
10.1039/b915765b
Self-assembly and application of diphenylalanine-based nanostructures.
X. Yan (2010)
10.1016/J.COLSURFA.2009.02.003
Synthesis and characterization of Fe and Fe3O4 nanoparticles by thermal decomposition of triiron dodecacarbonyl
Daniel Amara (2009)
10.1080/02656730500532028
Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field
H. Kampinga (2006)
10.1007/s11060-009-0093-0
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results
C. Wismeth (2009)
10.1016/0360-3016(94)90571-1
Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
R. N. Shen (1994)
10.1002/jat.3273
Rhamnose‐coated superparamagnetic iron‐oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity
Alessandro Paolini (2016)
10.1016/J.JMMM.2013.08.039
Study of AC magnetic heating characteristics of Co0.5Zn0.5Fe2O4 nanoparticles for magnetic hyperthermia therapy
Dipali S. Nikam (2014)
10.1021/acs.accounts.5b00038
Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Daishun Ling (2015)
10.1039/c3nr04793h
Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.
Daniel L. Nordmeyer (2014)
10.1088/0957-0233/23/3/035701
On the measurement technique for specific absorption rate of nanoparticles in an alternating electromagnetic field
Shujuan Huang (2012)
10.1016/J.JLUMIN.2006.10.018
Synthesis and room temperature photoluminescence of ZnO/CTAB ordered layered nanocomposite with flake-like architecture
Y. Wang (2007)
10.1016/J.CATCOM.2013.05.017
Supported iron oxide nanoparticles: Recoverable and efficient catalyst for oxidative S-S coupling of thiols to disulfides
F. Rajabi (2013)
10.1089/jamp.2013.1117
Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs).
H. Graczyk (2015)
10.1021/am302883m
Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications.
Hongdong Cai (2013)
10.1007/978-981-10-2529-7_5
Superparamagnetic Iron Oxide Nanoparticles
S. Laurent (2017)
10.1021/nn102762f
Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy.
Charles Sanson (2011)
10.1038/nnano.2011.145
The Scherrer equation versus the 'Debye-Scherrer equation'.
U. Holzwarth (2011)
10.1039/c5nr03777h
Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica nanoparticles.
P. Saint-Cricq (2015)
10.1039/C5TB02464A
Magnetically triggered drug release from biocompatible microcapsules for potential cancer therapeutics.
Hongmei Bi (2016)
10.1002/(SICI)1097-4652(199810)177:1<137::AID-JCP15>3.0.CO;2-A
Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia
R. Burd (1998)
10.1016/S0304-8853(02)01066-1
Size dependent magnetic properties of iron oxide nanoparticles
J. Chatterjee (2003)
10.1080/14686996.2016.1222494
Structural behavior of laser-irradiated γ-Fe2O3 nanocrystals dispersed in porous silica matrix : γ-Fe2O3 to α-Fe2O3 phase transition and formation of ε-Fe2O3
Y. El Mendili (2016)
10.1016/j.jconrel.2013.01.013
Magnetic field triggered drug release from polymersomes for cancer therapeutics.
Hugo Oliveira (2013)
10.1080/02656730310001637334
Role of nuclear protein denaturation and aggregation in thermal radiosensitization
J. Lepock (2004)
10.1039/c4cc05358c
Enzyme immobilised novel core-shell superparamagnetic nanocomposites for enantioselective formation of 4-(R)-hydroxycyclopent-2-en-1-(S)-acetate.
M. E. Sharifabad (2014)
10.3109/02656736.2013.790092
Simulation techniques in hyperthermia treatment planning
M. Paulides (2013)
10.1109/20.718537
Physical limits of hyperthermia using magnetite fine particles
R. Hergt (1998)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.3109/02656736.2015.1040471
Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
N. Cihoric (2015)
10.1016/J.MICROMESO.2008.06.010
On the estimation of average crystallite size of zeolites from the Scherrer equation: A critical evaluation of its application to zeolites with one-dimensional pore systems
A. Burton (2009)
10.1016/S1470-2045(02)00818-5
Hyperthermia in combined treatment of cancer.
P. Wust (2002)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar